Switch theme
Sign up to access all valuation multiples
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
162
Last FY Revenue $42.1M
Last FY EBITDA $7.9M
$102M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Limes Schlosskliniken achieved revenue of $42.1M and an EBITDA of $7.9M.
Limes Schlosskliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Limes Schlosskliniken valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $42.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $38.8M | XXX | XXX | XXX |
| Gross Margin | XXX | 92% | XXX | XXX | XXX |
| EBITDA | XXX | $7.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 19% | XXX | XXX | XXX |
| EBIT | XXX | $4.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | 11% | XXX | XXX | XXX |
| Net Profit | XXX | $3.5M | XXX | XXX | XXX |
| Net Margin | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Limes Schlosskliniken's stock price is EUR 310 (or $348).
Limes Schlosskliniken has current market cap of EUR 90.9M (or $102M), and EV of EUR 90.5M (or $102M).
See Limes Schlosskliniken trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $102M | $102M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Limes Schlosskliniken has market cap of $102M and EV of $102M.
Limes Schlosskliniken's trades at 2.4x EV/Revenue multiple, and 12.8x EV/EBITDA.
Equity research analysts estimate Limes Schlosskliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Limes Schlosskliniken's P/E ratio is not available.
See valuation multiples for Limes Schlosskliniken and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $102M | XXX | $102M | XXX | XXX | XXX |
| EV (current) | $102M | XXX | $102M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 12.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 21.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 29.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 36.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLimes Schlosskliniken's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Limes Schlosskliniken's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Limes Schlosskliniken's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Limes Schlosskliniken and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Limes Schlosskliniken acquired XXX companies to date.
Last acquisition by Limes Schlosskliniken was XXXXXXXX, XXXXX XXXXX XXXXXX . Limes Schlosskliniken acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| Where is Limes Schlosskliniken headquartered? | Limes Schlosskliniken is headquartered in Germany. |
| How many employees does Limes Schlosskliniken have? | As of today, Limes Schlosskliniken has 162 employees. |
| Is Limes Schlosskliniken publicy listed? | Yes, Limes Schlosskliniken is a public company listed on DUS. |
| What is the stock symbol of Limes Schlosskliniken? | Limes Schlosskliniken trades under LIK ticker. |
| When did Limes Schlosskliniken go public? | Limes Schlosskliniken went public in 2018. |
| Who are competitors of Limes Schlosskliniken? | Similar companies to Limes Schlosskliniken include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Limes Schlosskliniken? | Limes Schlosskliniken's current market cap is $102M |
| Is Limes Schlosskliniken profitable? | Yes, Limes Schlosskliniken is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
